EMN Operational Stream Lead at Acadia Pharmaceuticals

Mumbai, Maharashtra, India

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Manufacturing, HealthcareIndustries

Skills

Key technologies and capabilities for this role

Operational LeadershipSupplier ManagementCMO OversightCross-functional GovernanceS&OPSupply Chain ManagementContract ManufacturingPerformance ManagementContinuous ImprovementStrategic PartnershipsResource AlignmentIssue Resolution

Questions & Answers

Common questions about this position

What is the employment type for this position?

This is a full-time position.

Is this role remote or does it require office presence?

This information is not specified in the job description.

What are the key responsibilities of the Operational Stream Lead?

The role involves leading operational performance across the External Manufacturing Network, managing CMO relationships, driving cross-functional collaboration, and handling supplier performance management.

What is the company culture like at Ferring Pharmaceuticals?

The culture emphasizes empowerment, where speaking up is valued, and growth and development are constant, with a focus on working together, sharing ideas, and ensuring quality, accuracy, and safety.

What makes a strong candidate for the Operational Stream Lead role?

Strong candidates will have experience in operational leadership, cross-functional collaboration across manufacturing, supply chain, quality, and regulatory functions, and expertise in managing supplier relationships and performance in a pharmaceutical manufacturing context.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI